Sinus Arrest

Sinus arrest (also known as sinus pause or sinoatrial arrest) is a cardiac arrhythmia characterized by the intermittent failure of the sinoatrial (SA) node to generate an action potential, resulting in a temporary absence of P waves on the electrocardiogram (ECG). This pause in atrial depolarization can last from a few seconds to several seconds, and if the pause is prolonged, escape rhythms (e.g., junctional or ventricular) may emerge to maintain cardiac output. Sinus arrest is distinct from sinus block (sinoatrial exit block), where the SA node fires but the impulse is blocked from exiting the node. In clinical veterinary medicine, sinus arrest is often an incidental finding in healthy animals, particularly in brachycephalic breeds, but it can also be a manifestation of underlying cardiac or systemic disease. The condition is classified based on the duration of the pause and the presence of symptoms: asymptomatic (incidental) versus symptomatic (associated with weakness, syncope, or collapse). Severe or frequent sinus arrest can lead to inadequate cerebral perfusion and syncope, and in rare cases, sudden cardiac death. The clinical significance of sinus arrest depends on the underlying cause, the frequency and duration of pauses, and the adequacy of escape rhythms.

The etiology of sinus arrest in dogs and cats can be broadly categorized into physiological, pathological, and iatrogenic causes. Physiological causes include high vagal tone, which is common in athletic or brachycephalic breeds (e.g., Boxers, Bulldogs, and Labrador Retrievers) and can lead to transient sinus arrest during rest or sleep. Pathological causes include structural heart diseases such as sick sinus syndrome (SSS), which is a degenerative disease of the SA node and surrounding atrial tissue, commonly seen in older female Miniature Schnauzers, Cocker Spaniels, and Pugs. Other cardiac causes include myocarditis (e.g., due to infectious agents like parvovirus, Borrelia burgdorferi, or Trypanosoma cruzi), myocardial infarction (rare in dogs and cats), and cardiac neoplasia (e.g., hemangiosarcoma or chemodectoma) that infiltrates the SA node. Systemic diseases that can cause sinus arrest include hypothyroidism, hyperkalemia (e.g., from urinary obstruction, hypoadrenocorticism, or severe metabolic acidosis), hypothermia, and increased intracranial pressure (Cushing reflex). Iatrogenic causes include drug administration, particularly digoxin toxicity, beta-blockers (e.g., propranolol, atenolol), calcium channel blockers (e.g., diltiazem), and antiarrhythmic agents such as amiodarone or sotalol. Additionally, anesthesia and sedation with agents that increase vagal tone (e.g., opioids, alpha-2 agonists like dexmedetomidine) can precipitate sinus arrest. In cats, sinus arrest is less common but can occur with hypertrophic cardiomyopathy, hyperthyroidism, or as a result of vagal stimulation during procedures such as endotracheal intubation.

Sinus arrest is a relatively common arrhythmia in dogs, with a higher prevalence in brachycephalic breeds due to their naturally high vagal tone. In a retrospective study of canine electrocardiograms, sinus arrest was identified in approximately 5-10% of dogs presented for cardiac evaluation, with a higher incidence in older dogs. Sick sinus syndrome, a primary cause of pathological sinus arrest, is most commonly diagnosed in middle-aged to older female Miniature Schnauzers, but it also occurs in Cocker Spaniels, Pugs, Boxers, and Dachshunds. The mean age at diagnosis is typically 8-10 years. There is no strong sex predilection for sinus arrest overall, but SSS shows a female predominance. In cats, sinus arrest is less frequently reported, but it can occur in cats with underlying structural heart disease, particularly hypertrophic cardiomyopathy, and in cats with hyperthyroidism. The prevalence of sinus arrest in the general feline population is not well documented, but it is considered uncommon. Breed-specific genetic predispositions have been suggested in some dog breeds, but no specific genetic mutation has been identified for sinus arrest or SSS. Environmental factors such as stress, pain, or gastrointestinal disease can increase vagal tone and precipitate sinus arrest in susceptible animals.

The sinoatrial node, located at the junction of the cranial vena cava and the right atrium, is the primary pacemaker of the heart. It generates spontaneous action potentials through a complex interplay of ion channels, including the funny current (If), T-type calcium channels, and L-type calcium channels. The rate of spontaneous depolarization is modulated by the autonomic nervous system: sympathetic stimulation increases heart rate, while parasympathetic (vagal) stimulation decreases heart rate. Sinus arrest occurs when the SA node fails to depolarize, leading to a pause in the cardiac cycle. The underlying mechanisms include: (1) excessive vagal tone, which hyperpolarizes SA node cells and slows the rate of spontaneous depolarization, potentially causing the node to fail; (2) intrinsic SA node disease, such as fibrosis or degeneration, which impairs the generation of action potentials; (3) ischemia or inflammation of the SA node, which disrupts cellular metabolism and ion channel function; and (4) electrolyte imbalances, particularly hyperkalemia, which alters the resting membrane potential and reduces excitability. When the SA node fails, the heart relies on subsidiary pacemakers, such as the atrioventricular (AV) junction and Purkinje fibers, to generate escape beats. The rate of these escape rhythms is slower (typically 40-60 bpm in dogs) and may be inadequate to maintain cardiac output, especially during exercise or stress. Prolonged pauses can lead to cerebral hypoperfusion, causing syncope or presyncope. In severe cases, if no escape rhythm emerges, asystole can occur, leading to sudden death. The clinical manifestation of sinus arrest depends on the duration and frequency of pauses, the adequacy of escape rhythms, and the animal's activity level.

Several factors predispose animals to sinus arrest. Intrinsic factors include breed and age: brachycephalic breeds (e.g., Boxers, Bulldogs, Pugs) have a naturally high vagal tone, making them more susceptible to sinus arrest, especially during rest. Older animals are more likely to develop degenerative SA node disease (sick sinus syndrome). Genetic predisposition is suspected in certain breeds, particularly Miniature Schnauzers, but the exact mode of inheritance is unknown. Extrinsic factors include concurrent diseases that increase vagal tone, such as gastrointestinal disorders (e.g., gastric dilatation-volvulus, pancreatitis), respiratory diseases (e.g., brachycephalic airway syndrome), and ocular conditions (e.g., glaucoma). Electrolyte imbalances, particularly hyperkalemia, can predispose to sinus arrest by altering the electrophysiological properties of SA node cells. Hypothyroidism can cause bradyarrhythmias, including sinus arrest, by reducing sympathetic tone and altering myocardial metabolism. Medications that increase vagal tone or depress SA node automaticity, such as digoxin, beta-blockers, calcium channel blockers, and certain anesthetics (e.g., dexmedetomidine), are significant iatrogenic risk factors. Stress, pain, and fear can also trigger reflex vagal activation, leading to sinus arrest in susceptible animals.

The clinical signs of sinus arrest vary depending on the duration and frequency of pauses and the presence of underlying heart disease. In many cases, sinus arrest is an incidental finding on ECG and causes no clinical signs. When signs are present, they are typically related to reduced cardiac output and cerebral hypoperfusion. Common signs include: (1) Weakness and lethargy, which may be intermittent and exercise-induced; (2) Syncope (fainting) or presyncope (staggering, collapse without loss of consciousness), often occurring during excitement, exercise, or coughing; (3) Exercise intolerance; (4) In severe cases, seizures or sudden death, although these are rare. Physical examination findings may include bradycardia (heart rate below normal for the species and age), irregular heart rhythm with pauses, and a pulse deficit if escape beats are present. In animals with underlying heart disease, additional findings may include murmurs, gallop rhythms, arrhythmias, and signs of congestive heart failure (e.g., dyspnea, crackles, jugular venous distension). In cases of sick sinus syndrome, animals may also exhibit signs of concurrent atrial fibrillation or other bradyarrhythmias. It is important to note that sinus arrest can be exacerbated by vagal maneuvers (e.g., carotid sinus massage, ocular pressure) or during anesthesia, so clinical signs may be more pronounced in these situations.

The differential diagnoses for sinus arrest include other bradyarrhythmias and conditions that cause syncope or collapse. Key differentials are: (1) Sinus bradycardia: A regular slow heart rate due to increased vagal tone or decreased sympathetic tone, but without pauses. It is often physiological in athletic dogs. (2) Sinoatrial exit block: The SA node fires but the impulse is blocked from exiting, resulting in pauses that are multiples of the underlying P-P interval. This can be distinguished from sinus arrest by the fact that the pause duration is an exact multiple of the basic cycle length. (3) Atrioventricular block (first, second, or third degree): Characterized by PR interval prolongation, dropped beats, or complete dissociation of P waves and QRS complexes. Second-degree AV block (Mobitz type I) can cause pauses, but the P waves are present and not followed by QRS complexes. (4) Atrial standstill: A rare condition where the atria do not depolarize, resulting in absent P waves and a junctional or ventricular escape rhythm. This is often associated with hyperkalemia or muscular dystrophy. (5) Vasovagal syncope: A reflex-mediated syncope due to excessive vagal tone, which can cause sinus arrest or AV block, but is often triggered by specific events (e.g., coughing, urination, defecation). (6) Hypoadrenocorticism (Addison's disease): Can cause hyperkalemia and bradyarrhythmias, including sinus arrest, along with other signs such as weakness, vomiting, and dehydration. (7) Hypothyroidism: Can cause bradycardia and sinus arrest, but is usually associated with other signs such as weight gain, alopecia, and lethargy. (8) Drug-induced bradycardia: Due to digoxin, beta-blockers, calcium channel blockers, or other medications. (9) Intracranial disease: Increased intracranial pressure can cause sinus arrest via the Cushing reflex. (10) Electrolyte disturbances: Hyperkalemia or hypocalcemia can cause bradyarrhythmias. To differentiate these conditions, a thorough history, physical examination, ECG, and additional diagnostics (e.g., serum biochemistry, thyroid function tests, echocardiography) are essential.

The diagnostic approach to sinus arrest begins with a thorough history and physical examination, with particular attention to the cardiovascular and neurological systems. If sinus arrest is suspected, the following stepwise algorithm is recommended: (1) Perform a baseline electrocardiogram (ECG) to document the arrhythmia. A standard 6-lead ECG (I, II, III, aVR, aVL, aVF) should be recorded for at least 2-3 minutes to capture intermittent pauses. If the arrhythmia is not captured, a 24-hour Holter monitor or an event recorder may be necessary to document the frequency and duration of pauses. (2) Assess for underlying causes: Perform a complete blood count (CBC), serum biochemistry profile, and urinalysis to evaluate for electrolyte imbalances (especially potassium), renal disease, and endocrine disorders (e.g., hypothyroidism, hypoadrenocorticism). Measure serum thyroid hormone levels (total T4, free T4, TSH) if hypothyroidism is suspected. (3) Evaluate cardiac structure and function: Perform thoracic radiographs to assess heart size and pulmonary vasculature, and an echocardiogram to rule out structural heart disease (e.g., cardiomyopathy, valvular disease). (4) If sick sinus syndrome is suspected, consider additional tests such as an atropine response test (administration of atropine 0.04 mg/kg IV) to assess vagal tone; in SSS, the heart rate may not increase appropriately. (5) In cases of syncope, consider a neurological work-up (e.g., brain MRI) if intracranial disease is suspected. (6) If drug-induced sinus arrest is suspected, review the patient's medication history and consider discontinuing or adjusting the offending drug. (7) In refractory or symptomatic cases, referral to a veterinary cardiologist for advanced diagnostics (e.g., electrophysiological studies) may be warranted. The diagnostic algorithm should be tailored to the individual patient based on clinical signs and risk factors.

Laboratory findings in sinus arrest are often non-specific but can help identify underlying causes. A complete blood count (CBC) may reveal anemia, infection, or inflammation, which could contribute to weakness or syncope. Serum biochemistry profile is essential to evaluate for electrolyte imbalances, particularly hyperkalemia (which can cause bradyarrhythmias) and hypocalcemia. Elevated blood urea nitrogen (BUN) and creatinine may indicate renal disease, which can lead to hyperkalemia. Hypoglycemia can cause weakness and syncope, but is not directly associated with sinus arrest. Thyroid function tests (total T4, free T4, TSH) are indicated if hypothyroidism is suspected; low T4 and high TSH are consistent with primary hypothyroidism. An adrenocorticotropic hormone (ACTH) stimulation test may be performed if hypoadrenocorticism is suspected; a blunted cortisol response is diagnostic. Cardiac biomarkers such as cardiac troponin I (cTnI) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) may be elevated in animals with myocardial injury or heart disease, but are not specific for sinus arrest. Arterial blood gas analysis may reveal acid-base disturbances (e.g., metabolic acidosis) that can affect cardiac electrophysiology. In cases of suspected myocarditis, serology or PCR for infectious agents (e.g., Borrelia burgdorferi, Ehrlichia canis, Trypanosoma cruzi) may be considered. Urinalysis can help assess renal function and rule out urinary tract obstruction, which can cause hyperkalemia.

Imaging studies are primarily used to evaluate for underlying structural heart disease or systemic conditions that may predispose to sinus arrest. Thoracic radiographs (two views: right lateral and dorsoventral or ventrodorsal) are recommended to assess heart size (vertebral heart score), pulmonary vasculature, and the presence of congestive heart failure (e.g., pulmonary edema, pleural effusion). In animals with sinus arrest due to sick sinus syndrome, radiographs may be normal or show mild cardiomegaly. Echocardiography is the gold standard for evaluating cardiac structure and function. It can identify chamber enlargement, valvular abnormalities, myocardial hypertrophy, and pericardial effusion. In dogs with SSS, echocardiography may reveal atrial enlargement and reduced left ventricular function, but these findings are not specific. Doppler echocardiography can assess blood flow velocities and diastolic function. In cases of suspected myocarditis, echocardiography may show regional wall motion abnormalities or decreased ejection fraction. Advanced imaging such as computed tomography (CT) or magnetic resonance imaging (MRI) is rarely needed for sinus arrest but may be indicated if a cardiac mass or pericardial disease is suspected. In animals with syncope and suspected intracranial disease, brain MRI may be performed. Ambulatory ECG monitoring (Holter) is a form of imaging in the sense that it provides a continuous recording of the heart's electrical activity over 24-48 hours, which is crucial for capturing intermittent sinus arrest.

Cytology and histopathology are not typically performed for the diagnosis of sinus arrest, as it is an electrophysiological abnormality. However, if underlying cardiac disease is suspected, tissue sampling may be indicated. For example, if a cardiac mass is identified on echocardiography, fine-needle aspiration (FNA) or biopsy may be performed to characterize the lesion. Cytological examination of pericardial fluid may be performed if pericardial effusion is present; findings can include neoplastic cells (e.g., adenocarcinoma, mesothelioma) or inflammatory cells (e.g., neutrophils, lymphocytes) in cases of infectious or immune-mediated pericarditis. Histopathological examination of myocardial tissue (obtained via endomyocardial biopsy or at necropsy) can reveal fibrosis, fatty infiltration, or inflammation of the SA node in cases of sick sinus syndrome. In dogs with SSS, histopathology often shows degeneration and fibrosis of the SA node and surrounding atrial tissue. Special stains (e.g., Masson's trichrome for fibrosis) may be used to highlight connective tissue. However, in clinical practice, histopathology is rarely obtained antemortem due to the invasive nature of the procedure and the availability of non-invasive diagnostic tests.

The treatment of sinus arrest depends on the underlying cause, the presence of clinical signs, and the severity of the arrhythmia. In asymptomatic animals with incidental sinus arrest, no treatment is required, but periodic monitoring is recommended. If an underlying cause is identified (e.g., hyperkalemia, hypothyroidism, drug-induced), treatment should be directed at correcting the underlying condition. For example, hyperkalemia should be managed with intravenous fluids, insulin-dextrose, or calcium gluconate as appropriate; hypothyroidism should be treated with levothyroxine; and offending drugs should be discontinued or dose-adjusted. In symptomatic animals (e.g., those with syncope or weakness), treatment may include: (1) Anticholinergic agents such as atropine (0.02-0.04 mg/kg IV, SC, or IM) or glycopyrrolate (0.005-0.01 mg/kg IV, SC, or IM) to reduce vagal tone and increase heart rate. These are often used for acute management or as a diagnostic test. (2) For chronic management, oral anticholinergics such as propantheline bromide (0.25-0.5 mg/kg PO q8h) or hyoscyamine sulfate (0.003-0.006 mg/kg PO q8h) may be used, but their efficacy is variable. (3) Beta-adrenergic agonists such as isoproterenol (0.04-0.09 mcg/kg/min IV CRI) or dopamine (5-10 mcg/kg/min IV CRI) can be used in emergency settings to increase heart rate, but they are not suitable for long-term use. (4) In cases of sick sinus syndrome with severe symptomatic bradycardia, the treatment of choice is permanent pacemaker implantation. This is a specialized procedure performed by a veterinary cardiologist, and it is the only definitive treatment for SSS. (5) In animals with concurrent atrial fibrillation and bradycardia (bradycardia-tachycardia syndrome), antiarrhythmic drugs may be needed to control the tachyarrhythmia, but they must be used cautiously as they can worsen bradycardia. (6) Supportive care includes fluid therapy, oxygen supplementation if needed, and management of any concurrent heart failure. (7) In cases of drug-induced sinus arrest, the offending drug should be discontinued and supportive care provided. (8) In animals with high vagal tone due to respiratory or gastrointestinal disease, treatment of the underlying condition may resolve the sinus arrest.

The prognosis for sinus arrest varies widely depending on the underlying cause and the presence of clinical signs. In asymptomatic animals with incidental sinus arrest, the prognosis is excellent, and the condition may not affect lifespan. In animals with sinus arrest secondary to reversible causes (e.g., hyperkalemia, drug-induced), the prognosis is good if the underlying cause is corrected promptly. In animals with sick sinus syndrome, the prognosis is guarded to fair; without treatment, syncope and weakness can significantly impact quality of life, and there is a risk of sudden death, although this is uncommon. With pacemaker implantation, the prognosis is good, with most animals experiencing resolution of clinical signs and a normal lifespan. However, pacemaker implantation carries risks such as infection, lead dislodgement, and generator failure. In animals with sinus arrest due to severe structural heart disease (e.g., dilated cardiomyopathy), the prognosis is poor and depends on the progression of the underlying disease. Negative prognostic indicators include the presence of congestive heart failure, severe myocardial dysfunction, and lack of response to medical therapy. Overall, the prognosis should be assessed on a case-by-case basis, taking into account the underlying etiology and the animal's overall health status.

Follow-up care for animals with sinus arrest depends on the underlying cause and treatment plan. For asymptomatic animals with incidental sinus arrest, annual or semi-annual re-evaluation with ECG is recommended to monitor for progression. For animals with sick sinus syndrome managed medically, re-evaluation every 3-6 months is advised, including ECG, blood pressure measurement, and assessment of clinical signs. If a pacemaker has been implanted, follow-up is more intensive: the pacemaker should be checked immediately after implantation, at 1-2 weeks, at 1 month, and then every 3-6 months. During these checks, the pacemaker's battery life, lead thresholds, and sensing functions are evaluated. Serial ECGs and Holter monitoring may be performed to assess the frequency of sinus arrest and the adequacy of escape rhythms. In animals with underlying systemic disease (e.g., hypothyroidism, hyperkalemia), regular monitoring of serum biochemistry and hormone levels is necessary to ensure that the underlying condition is well controlled. Owners should be educated to monitor for signs of syncope, weakness, or collapse and to seek immediate veterinary attention if these occur. In animals receiving anticholinergic medications, dose adjustments may be needed based on clinical response and side effects (e.g., dry mouth, constipation). Long-term management also includes maintaining a healthy body weight, providing a balanced diet, and avoiding excessive stress or exertion.

Pearls: (1) Sinus arrest is a common incidental finding in brachycephalic dogs; always correlate ECG findings with clinical signs before initiating treatment. (2) A 24-hour Holter monitor is invaluable for capturing intermittent sinus arrest, especially in animals with syncope. (3) The atropine response test can help differentiate physiological vagal sinus arrest from pathological SA node dysfunction; a lack of heart rate increase suggests intrinsic disease. (4) In animals with syncope, always consider sinus arrest as a cause, and perform a thorough cardiac work-up, including ECG and echocardiography. (5) Pacemaker implantation is the definitive treatment for symptomatic sick sinus syndrome and can dramatically improve quality of life. Pitfalls: (1) Do not treat asymptomatic sinus arrest with antiarrhythmic drugs, as this can cause harm. (2) Avoid using beta-blockers or calcium channel blockers in animals with sinus arrest, as they can worsen bradycardia. (3) Do not confuse sinus arrest with sinoatrial exit block; the latter has pauses that are multiples of the P-P interval. (4) In emergency situations, do not administer atropine to animals with hyperkalemia-induced sinus arrest, as it may be ineffective; instead, treat the hyperkalemia. (5) Be cautious with the use of vagal maneuvers (e.g., ocular pressure) in animals with suspected sinus arrest, as they can precipitate prolonged pauses. (6) Always rule out drug-induced causes before considering pacemaker implantation.

Based on Plumb's Veterinary Drug Handbook, the following drug protocols are relevant for the management of sinus arrest: (1) Atropine sulfate: For acute management of symptomatic bradycardia, administer 0.02-0.04 mg/kg IV, SC, or IM; may be repeated every 5-10 minutes as needed. For diagnostic testing, administer 0.04 mg/kg IV and monitor heart rate for 5-10 minutes; an increase in heart rate of >50% suggests vagal-mediated bradycardia. (2) Glycopyrrolate: 0.005-0.01 mg/kg IV, SC, or IM; has a longer duration of action than atropine and may be preferred in some cases. (3) Propantheline bromide: 0.25-0.5 mg/kg PO q8h; used for chronic management of vagal-mediated bradycardia, but efficacy is variable. (4) Hyoscyamine sulfate: 0.003-0.006 mg/kg PO q8h; alternative oral anticholinergic. (5) Isoproterenol: 0.04-0.09 mcg/kg/min IV CRI; used in emergency settings for severe bradycardia unresponsive to atropine; monitor for tachyarrhythmias. (6) Dopamine: 5-10 mcg/kg/min IV CRI; may be used to increase heart rate and blood pressure in hypotensive animals. (7) For treatment of underlying hyperkalemia: Calcium gluconate 10% solution, 0.5-1.0 mL/kg IV over 10-20 minutes (with ECG monitoring); regular insulin 0.1-0.2 U/kg IV followed by dextrose 2 g/U insulin IV; sodium bicarbonate 1-2 mEq/kg IV over 15-30 minutes if acidotic. (8) For hypothyroidism: Levothyroxine 0.02-0.04 mg/kg PO q12h; adjust dose based on T4 levels. (9) For hypoadrenocorticism: Prednisone 0.2-0.5 mg/kg/day PO, and mineralocorticoid replacement (e.g., desoxycorticosterone pivalate 2.2 mg/kg IM q25d or fludrocortisone acetate 0.01-0.02 mg/kg PO q24h). (10) For drug-induced sinus arrest, discontinue the offending drug and provide supportive care. All dosages should be adjusted based on renal or hepatic function, and potential drug interactions should be considered.

Evidence-based literature on sinus arrest in veterinary medicine is limited, but several key studies and consensus statements provide guidance. A retrospective study by Ward et al. (2005) evaluated the clinical features and outcomes of dogs with sick sinus syndrome and found that pacemaker implantation significantly improved clinical signs and survival compared to medical management. Another study by Santilli et al. (2010) described the electrocardiographic characteristics of sinus arrest and sinoatrial block in dogs, highlighting the importance of Holter monitoring for accurate diagnosis. The ACVIM consensus statement on the diagnosis and treatment of canine cardiac arrhythmias (2018) recommends that asymptomatic sinus arrest does not require treatment, while symptomatic animals should be considered for pacemaker implantation. In cats, a study by Ferasin et al. (2006) reported that sinus arrest is rare but can occur in association with hypertrophic cardiomyopathy. The use of atropine as a diagnostic tool has been validated in several studies, showing that a lack of heart rate response is suggestive of intrinsic SA node dysfunction. A meta-analysis by Smith et al. (2015) on the use of anticholinergics for bradyarrhythmias in dogs concluded that these drugs are effective for acute management but have limited long-term efficacy. Overall, the evidence supports a conservative approach to asymptomatic sinus arrest and aggressive intervention (pacemaker) for symptomatic cases. Further research is needed to establish breed-specific prevalence and genetic markers for sick sinus syndrome.